SILO Pharma Profit Margin

The latest profit margin for SILO is -6717.4% as of March 2026. That compares with -6411.26% in the prior-year period — down 4.8% year over year. That is below the Finance sector average of 17.31%. Investors often review this figure alongside SILO Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, SILO's profit margin moved from -6411.26% to -6717.4% — a 4.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in SILO Pharma's valuation or profitability profile.

Against Finance companies, SILO currently prints -6717.4% for profit margin, while the sector average sits near 17.31%. That is roughly 38896.8% below the sector mean. Large gaps often invite a closer look at SILO Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively SILO Pharma converts resources into returns. At -6717.4%, SILO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6411.26% in the prior-year period — down 4.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SILO's profit margin (-6717.4%), review year-over-year change from -6411.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.